The long-term objective of the ICTUS study is to identify milestones in Alzheimer's disease (AD) progression and to develop a model to predict disease course in individual AD patients in Europe. The secondary objectives are to describe the patterns of prescribing, and the socioeconomic impact of AD in Europe. Between 2003 and 2005 1,380 patients with probable AD were recruited in specialised (secondary care) clinics in 12 European countries. Their mean age was 76 years and they had a mean of 8.0 ± (SD) 4.6 years of education. Thirty-five percent were male. The mean MMSE score was 20.4 ± (SD) 4.0. Forty-three percent had very mild dementia (CDR 0.5) and 44% had mild dementia (CDR 1). All patients completed baseline evaluation and biannual fo...
Purpose: Real-world studies to describe the use of first, second and third line therapies for the ma...
International audienceObjective We aimed to study the epidemiology of the prodromal and mild stages ...
Background: The course of Alzheimer’s disease (AD) varies considerably between individuals. There is...
The long-term objective of the ICTUS study is to identify milestones in Alzheimer's disease (AD) pro...
The clinical progression of Alzheimer disease (AD) was studied in European subjects under treatment ...
The clinical progression of Alzheimer disease (AD) was studied in European subjects under treatment ...
BACKGROUND: Different rates of cognitive progression have been observed among Alzheimer disease (AD...
Item does not contain fulltextBACKGROUND: We aimed to describe longitudinal patterns of care in comm...
Objectives: This study aimed to estimate the costs of formal and informal care of patients with Alzh...
International audienceABSTRACT: BACKGROUND: Cognitive impairment and Alzheimer's disease (AD) are in...
BACKGROUND: The European Prevention of Alzheimer's Dementia (EPAD) Programme is a pan-European proje...
International audienceLongitudinal observational cohort studies are being conducted worldwide to und...
Abstract: Background: The European Prevention of Alzheimer’s Dementia (EPAD) Programme is a pan-Euro...
Longitudinal observational cohort studies are being conducted worldwide to understand cognition, bio...
Background: Different rates of cognitive progression have been observed among Alzheimer disease (AD...
Purpose: Real-world studies to describe the use of first, second and third line therapies for the ma...
International audienceObjective We aimed to study the epidemiology of the prodromal and mild stages ...
Background: The course of Alzheimer’s disease (AD) varies considerably between individuals. There is...
The long-term objective of the ICTUS study is to identify milestones in Alzheimer's disease (AD) pro...
The clinical progression of Alzheimer disease (AD) was studied in European subjects under treatment ...
The clinical progression of Alzheimer disease (AD) was studied in European subjects under treatment ...
BACKGROUND: Different rates of cognitive progression have been observed among Alzheimer disease (AD...
Item does not contain fulltextBACKGROUND: We aimed to describe longitudinal patterns of care in comm...
Objectives: This study aimed to estimate the costs of formal and informal care of patients with Alzh...
International audienceABSTRACT: BACKGROUND: Cognitive impairment and Alzheimer's disease (AD) are in...
BACKGROUND: The European Prevention of Alzheimer's Dementia (EPAD) Programme is a pan-European proje...
International audienceLongitudinal observational cohort studies are being conducted worldwide to und...
Abstract: Background: The European Prevention of Alzheimer’s Dementia (EPAD) Programme is a pan-Euro...
Longitudinal observational cohort studies are being conducted worldwide to understand cognition, bio...
Background: Different rates of cognitive progression have been observed among Alzheimer disease (AD...
Purpose: Real-world studies to describe the use of first, second and third line therapies for the ma...
International audienceObjective We aimed to study the epidemiology of the prodromal and mild stages ...
Background: The course of Alzheimer’s disease (AD) varies considerably between individuals. There is...